BAX250502C23000
- 6.70
- 0.000.00%
Baxter International Inc Newsroom
Is There An Opportunity With Baxter International Inc.'s (NYSE:BAX) 50% Undervaluation?
Earnings Preview: BAX to Report Financial Results Pre-market on May 01
What Does the Market Think About Baxter Intl?
Tariff clouds loom heavy! Barclays names the U.S. stock medical instruments Industry as the 'pressure-resistant king' and the 'hard-hit area'.
Barclays issued a research report analyzing the impact of the new tariff policy of the Trump administration on the medical instruments industry.
Barclays Names Most and Least Affected Healthcare Companies From Tariffs
Top SA Quant-rated Healthcare Stocks as Q1 Earnings Unfold
Press Release: Baxter to Host First-Quarter 2025 Financial Results Conference Call for Investors
Baxter Launches New Room Temperature Hemopatch Sealing Hemostat for Rapid and Convenient Application During Surgery
Baxter International Inc. Stock Outperforms Competitors On Strong Trading Day
Pharma, MedTech Stocks Bounce Back as Trump Pauses Most Tariffs
Express News | Baxter Down 5.5%, Abbott Down 2.3%, Becton Dickinson Down 2.9%, Illumina Down 5.3%, Dexcom Down 2.2%, Medtronic Down 2.1%, Stryker Down 3.5%
Express News | Shares of Medical Device Makers Fall Amid Broad Market Selloff
Express News | Baxter : Citigroup Cuts Target Price to $35 From $37
Baxter International (NYSE:BAX) CEO Change as Stock Dips 2% Last Quarter
Evercore ISI Adjusts Baxter International Price Target to $45 From $44, Maintains Outperform Rating
Baxter International (NYSE:BAX) Investors Are Sitting on a Loss of 56% If They Invested Five Years Ago
Peering Into Baxter Intl's Recent Short Interest
RFK Jr. Reportedly Plans 10,000 Job Cuts in HHS With FDA, CDC, Medicare Affected
Baxter to Host Annual Meeting of Stockholders in Virtual Format
Hospital Stocks Are Ready to Rebound, Deutsche Bank Says